Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04632238 · ClinicalTrials.gov registry record · NA
Coaching Performance Driven Practice Change in the Context of Value Based Purchasing Under New York Medicaid
A NA study of Opioid Use Disorder and Substance Use Disorders, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 7,950
- Enrollment target
- 4
- Study locations
NCT04632238 is a NA study of Opioid Use Disorder and Substance Use Disorders that has completed, run by NYU Langone Health. The registered enrollment target is 7,950 participants, above the 4,625-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (72% higher). The trial reports 4 study locations across 1 state.
The verdict
NCT04632238, a NA study of Opioid Use Disorder and Substance Use Disorders, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 7,950 participants
- Enrollment target
- 4
- Study locations
Study Summary
This project will develop and test quality measures for and a facilitation model to help addictions treatment clinics increase use of medicines for opioid use disorders, retain clients longer in care, and help more people move into successful recovery. At the end of the project, we will have developed specific training and coaching protocols as well as electronic clinical support tools to guide quality improvement that can be disseminated within New York and the rest of the country. The study will test a clinic-level intervention that uses external facilitators to provide guidance to addictions clinics and contain three key components: 1) training on data driven management; 2) training and guidance on patient-centered care and OUD medication; and 3) electronic tools for shared decision making and patient progress monitoring.
Conditions Studied
Interventions
- BEHAVIORAL Metrics-driven quality improvement (MDQI)
Study Locations (4)
New York
- Samaritan Rockland - Outpatient Program - Blauvelt
- Samaritan Queens - Jamaica IOP - Jamaica
- Samaritan Daytop Village Harlem - Outpatient Program - New York
- Upper Manhattan Addiction Treatment Services Program - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,950 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04632238
The ClinicalTrials.gov registry entry for NCT04632238 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7,950 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 4,625-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (72% higher). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Metrics-driven quality improvement (MDQI) is the first listed.
NCT04632238 reports 4 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04632238 about?
NCT04632238 is a clinical study titled "Coaching Performance Driven Practice Change in the Context of Value Based Purchasing Under New York Medicaid". This project will develop and test quality measures for and a facilitation model to help addictions treatment clinics increase use of medicines for opioid use disorders, retain clients longer in care, and help more people move into successful recovery. At the end of the project, we will have develop...
What is the current status of trial NCT04632238?
This trial is currently completed. It is a NA study. The enrollment target is 7,950 participants. The study started on 2020-07-01. Estimated completion is 2025-06-30.
What conditions does trial NCT04632238 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Substance Use Disorders.
What interventions are being tested in trial NCT04632238?
The interventions under investigation include: Metrics-driven quality improvement (MDQI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04632238?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04632238 being conducted?
This trial has 4 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.